Annual Working Capital
$144.31 M
-$56.49 M-28.13%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual working capital is $144.31 million, with the most recent change of -$56.49 million (-28.13%) on December 31, 2023.
- During the last 3 years, BRNS annual working capital has risen by +$104.05 million (+258.44%).
- BRNS annual working capital is now -33.07% below its all-time high of $215.61 million, reached on December 31, 2021.
Performance
BRNS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$119.58 M
+$3.29 M+2.83%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly working capital is $119.58 million, with the most recent change of +$3.29 million (+2.83%) on September 30, 2024.
- Over the past year, BRNS quarterly working capital has stayed the same.
- BRNS quarterly working capital is now -51.82% below its all-time high of $248.19 million, reached on June 1, 2021.
Performance
BRNS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BRNS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.1% | 0.0% |
| 3 y3 years | +258.4% | -40.5% |
| 5 y5 years | +1274.7% | -51.8% |
BRNS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.1% | at low | -44.5% | +2.8% |
| 5 y | 5-year | -33.1% | +1274.7% | -51.8% | +197.0% |
| alltime | all time | -33.1% | +1274.7% | -51.8% | +197.0% |
Barinthus Biotherapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $119.58 M(+2.8%) |
| Jun 2024 | - | $116.29 M(-10.7%) |
| Mar 2024 | - | $130.30 M(-9.7%) |
| Dec 2023 | $144.31 M(-28.1%) | $144.31 M(-5.4%) |
| Sep 2023 | - | $152.50 M(-11.7%) |
| Jun 2023 | - | $172.67 M(-8.5%) |
| Mar 2023 | - | $188.68 M(-6.0%) |
| Dec 2022 | $200.80 M | $200.80 M(-1.9%) |
| Sep 2022 | - | $204.59 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $214.13 M(-0.1%) |
| Mar 2022 | - | $214.30 M(-0.6%) |
| Dec 2021 | $215.61 M(+435.5%) | - |
| Dec 2021 | - | $215.61 M(-10.0%) |
| Sep 2021 | - | $239.61 M(-3.5%) |
| Jun 2021 | - | $248.19 M(+60.4%) |
| Mar 2021 | - | $154.72 M(+284.3%) |
| Dec 2020 | $40.26 M(+283.5%) | $40.26 M |
| Dec 2019 | $10.50 M | - |
FAQ
- What is Barinthus Biotherapeutics annual working capital?
- What is the all time high annual working capital for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual working capital year-on-year change?
- What is Barinthus Biotherapeutics quarterly working capital?
- What is the all time high quarterly working capital for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly working capital year-on-year change?
What is Barinthus Biotherapeutics annual working capital?
The current annual working capital of BRNS is $144.31 M
What is the all time high annual working capital for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual working capital is $215.61 M
What is Barinthus Biotherapeutics annual working capital year-on-year change?
Over the past year, BRNS annual working capital has changed by -$56.49 M (-28.13%)
What is Barinthus Biotherapeutics quarterly working capital?
The current quarterly working capital of BRNS is $119.58 M
What is the all time high quarterly working capital for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly working capital is $248.19 M
What is Barinthus Biotherapeutics quarterly working capital year-on-year change?
Over the past year, BRNS quarterly working capital has changed by $0.00 (0.00%)